{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":300,"width":600,"title":"Novel Pathways in Cardiometabolic and Liver Health: An Interdisciplinary Dialogue","description":"Metabolic dysfunction-associated steatotic liver disease (MASLD) plays a pivotal role in cardiometabolic health, driven by its bidrectional relationship with cardiovascular disease (CVD) and its impact on long-term morbidity and mortality. This interdisciplinary vodcast explores the shared pathophysiologic pathways connecting MASLD and CVD and underscores the importance of comprehensive risk evaluation. A panel of experts discusses practical, evidence-based strategies for managing MASLD, including lifestyle interventions and the evolving landscape of pharmacologic therapies. The program highlights emerging cardiometabolic agents, including GLP 1-based therapies, ande their potential to slow disease progression and reduce cardiovascular risk in affected patients.&amp;nbsp; ","author_name":"HeartBEATS from Lifelong Learning\u2122","author_url":"https:\/\/professional.heart.org\/professional\/EducationMeetings\/UCM_475320_Education-Meetings.jsp","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/41005915\/height\/300\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"300\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/201153845"}